Clinical, Morphologic, Cytogenetic and Prognostic Implications of CD34 Expression in Childhood and Adult de novo AML

References

• Civin C. I., Strauss L. C., Brovall C., Fackler M. J., Schawartz J. F., Shaper J. H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Katz F. E., Tindle R., Sutherland D. R., Greaves M. F. Identification of a membrane glycoprotein associated with hematopoietic progenitor cells. Leuk. Res. 1985; 9: 191–198
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Singer J. W., Bernstein I. D. Monoclonal antibody 12–8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842–845
   PubMed Web of Science ®Google Scholar
• Tindle R. W., Nichols R. A. B., Chan L., Campana U., Catovsky D., Birnie G. D. A novel monoclonal antibody BI-3C5 recognizes myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk. Res. 1985; 9: 1–9
   PubMed Web of Science ®Google Scholar
• Vaughan W. P., Civin C. I., Weisenburger D. D., Karp J. E., Graham M. L., Sanger W. G., Grierson H. L., Joshi S. S., Burke P. J. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY 10). Leukemia 1988; 2: 661–666
   PubMed Web of Science ®Google Scholar
• Batinic D., Tindle R., Boban D., Tiefenbach A., Rajic L., Labar B., Nemet D., Boranic M. Expression of haematopoietic progenitor cell-associated antigen BI-3C5/CD34 in leukaemia. Leuk. Res. 1989; 13: 83–85
   PubMed Web of Science ®Google Scholar
• Fina L., Molgaard H. V., Robertson D., Bradley N. J., Monaghan P., Delia D., Sutherland D. R., Baker M. A., Greaves M. F. Expression of the CD34 gene in vascular endothelial cells. Blood 1990; 75: 2417–2426
   PubMed Web of Science ®Google Scholar
• Traweek S. T., Kandalaft P. L., Mehta P., Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am. J. Clin. Pathol. 1991; 96: 25–31
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Brown J., Molgaard H. V., Spurr N. K., Robertson D., Delia D., Sutherland D. R. Molecular features of CD34: a hemopoietic progenitor cell-associated molecule. Leukemia 1992; 6(Suppl. 1)31–36
   PubMedGoogle Scholar
• Simmons P. J., Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood 1991; 78: 2848–2853
   PubMed Web of Science ®Google Scholar
• Strauss L. C., Rowley S. D., La Russ V. F., Sharkis S. J., Stuart R. K., Civin C. I. Antigenic analysis of hematopoiesis. V. Characterisation of My-10 antigen expression by normal lym-phohematopoietic progenitor cells. Exp. Hemaiol. 1986; 14: 878–886
   PubMed Web of Science ®Google Scholar
• Huang S., Terstappen L. W. M. M. Lymphoid and myeloid differentiation of single human CD34+ HLA-DR-, CD38-hematopoietic stem cells. Blood 1994; 83: 1515–1526
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Andrews R. G., Bensinger W. I., Kalamasz D., Knitter G., Buckner C. D., Bernstein I. D. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 1988; 81: 951–955
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Garcia-Lopez J., Kalamaz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D., Thomas E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722
   PubMed Web of Science ®Google Scholar
• Shpall E. J., Jones R. B., Bearman S. I., Franklin W. A., Archer P. G., Curiel T., Bitter M., Claman H. N., Stemmer S. M., Purdy M., Myers S. E., Hami L., Taffs S., Heimfeld S., Hallagan J., Berenson R. J. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 1994; 12: 28–36
   PubMed Web of Science ®Google Scholar
• Sutherland D. R., Watt S. M., Dowden G., Karhi K., Baker M. A., Greaves M. F., Smart J. E. Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34. Leukemia 1988; 2: 793–803
   PubMed Web of Science ®Google Scholar
• Simmons D. L., Satterthwaite A. B., Tenen D. G., Seed B. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J. Immunol. 1992; 148: 267–271
   PubMed Web of Science ®Google Scholar
• Molgaard H. V., Spurr N. K., Greaves M. F. The hemopoietic stem cell antigen, CD34, is encoded by a gene located on chromosome 1. Leukemia 1989; 3: 773–776
   PubMed Web of Science ®Google Scholar
• Tenen D. G., Satterhwaite A. B., Borson R., Simmons D., Eddy R. L., Shows T. B. Chromosome I localization of the gene for CD34, a surface antigen of human stem cells. Cytogenet. Cell Genet. 1990; 53: 55–57
   PubMedGoogle Scholar
• Howell S. M., Molgaard H. V., Greaves M. F., Spurr N. K. Localisation of the gene coding for the haemopoietic stem cell antigen CD34 to chromosome Iq32. Hum. Genet. 1991; 87: 625–627
   PubMed Web of Science ®Google Scholar
• Nakamura Y., Komano H., Nakauchi H. Two alternative forms of cDNA encoding CD34. Exp. Hematol. 1993; 21: 236–242
   PubMed Web of Science ®Google Scholar
• He X.-Y., Antao V. P., Basila D., Marx J. C., Davis B. R. Isolation and characterization of the human CD34 gene. Blood 1992; 79: 2296–2302
   PubMed Web of Science ®Google Scholar
• Delia D., Lampugnani M. G., Resnati M., Dejana E., Aiello A., Fontanella E., Soligo D., Pierotti M. A., Greaves M. F. CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood 1993; 81: 1001–1008
   PubMed Web of Science ®Google Scholar
• Majdic O., Stöckl J., Pickl W. F., Bohuslav J., Strobl H., Scheinecker C., Stockinger H., Knapp W. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 1994; 83: 1226–1234
   PubMed Web of Science ®Google Scholar
• Silvestri F., Banavali S., Baccarani M., Preisler H. D. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications. Haematologica 1992; 11: 265–273
   Google Scholar
• Borowitz M. J., Gockerman J. P., Moore J. O., Civin C. I., Page S. O., Robertson J., Bigner S. H. Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic Leukemia. Am. J. Clin. Pathol 1989; 91: 265–270
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme O., Ehrsam A., Fiere D. Surface marker expression in adult acute myeloid leukemia: correlations with initial characteristics, morphology and response to therapy. Br. J. Haematol. 1989; 72: 161–166
   PubMed Web of Science ®Google Scholar
• Merle-Béral H., Cong Nguyen, Due L., Leblond V., Boucheix C., Michael A., Chastang C., Debré P. Diagnostic and prognostic significance of myelomonocytic cell surface antigens in acute myeloid leukaemia. Br. J. Haematol. 1989; 73: 323–330
   PubMed Web of Science ®Google Scholar
• Geller R., Zahurak M., Hurwitz C. A., Burke P. J., Karp J. E., Piantadosi S., Civin C. I. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My 10). Br. J. Haematol. 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Lee E. J., Yang J., Leavitt R. D., Testa J. R., Civin C. I., Forrest A., Schiffer C. A. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia 1992; 6: 1203–1209
   PubMed Web of Science ®Google Scholar
• Solary E., Casanovas R. O., Campos L., Bene M. C., Faure G., Maignon P., Falkenrodt, Lenormand B., Genetet N. Surface markers in adult acute myeloblasts leukemia: correlation of CD19+, CD34+ and CD14+/DR-phenotypes with shorter survival. Leukemia 1992; 6: 393–399
   PubMed Web of Science ®Google Scholar
• Smith F. O., Lampkin B., Versteeg C., Flowers D., Dinndorf P., Buckley J., Woods W., Hammond D., Bernstein I. D. Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. Blood 1992; 79: 2415–2422
   PubMed Web of Science ®Google Scholar
• Kuerbitz S. J., Civin C. I., Krischer J. P., Ravindranath Y., Steuber C. P., Weinstein H. J., Winick N., Ragab A. H., Gresik M. V., Crist W. M. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a pediatric oncology group study. J. Clin. Oncol. 1992; 10: 1419–1429
   PubMed Web of Science ®Google Scholar
• Sperling C., Seibt-Jung H., Gassmann W., Komischke B., Sauerland C., Hiddemann W., Loffler H., Buchner T., Thiel E., Ludwig W.-D. Immunophenotype of acute myeloid leukemia: correlation with morphological characteristics and therapy response. Recent Advances in Cell Biology of Acute Leukemias, W.-D. Ludwig, E. Thiel. Springer, Berlin, Heidelberg New York 1993; 381–392, (Recent Results in Cancer Research, Vol. 131)
   Google Scholar
• Civin C. I., Trischmann T. M., Fackler M. J., Bernstein I. D., Buehring H. J., Campos L., Greaves M. F., Kamoun M., Katz D. R., Lansdorp P. M., Look A. T., Seed B., Sutherland D. R., Tindle R. W., Uchanska-Ziegler B. Report on the CD34 cluster workshop. Leucocyte typing IV. White cell differention antigens, W. Knapp, B. Dörken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, A. E. G. K. von dem Borne. Oxford University Press, Oxford 1989; 818–825
   Google Scholar
• Pui C. H., Hancock M. L., Head D. R., Rivera G. K., Look A. T., Sandlund J. T., Behm F. G. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 1993; 82: 889–894
   PubMed Web of Science ®Google Scholar
• Ludwig W.-D., Reiter A., Löffler H., Gokbuget, Hoelzer D., Riehm H., Thiel E. Immunophenotypic features of childhood and adult acute lyphoblastic leukemia (ALL): experience of the German multicentre trials ALL-BFM and GMALL. Leuk. Lymphoma 1994; 13(Suppl. 1)71–76
   PubMed Web of Science ®Google Scholar
• Fagioli F., Cuneo A., Piva N., Carli M. G., Previati R., Balboni M., Tomasi P., Cariani D., Scapoli G., Castoldi G. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. Cancer 1992; 70: 77–85
   PubMed Web of Science ®Google Scholar
• Adriaansen H. J., Boekhorst P. A. W., Hagemeijer A. M., van der Schoot C. E., Delwell H. R., van Dongen J. J. M. Acute myeloid leukemia M4 with bone marrow eosinophilia(M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993; 81: 3043–3051
   PubMed Web of Science ®Google Scholar
• Sperling C., Buchner T., Sauerland C., Fonatsch C., Thiel E., Ludwig W.-D. CD34 expression in de novo acute myeloid leukaemia. Br. J. Haematol. 1993; 85: 635–637
   PubMed Web of Science ®Google Scholar
• Kita K., Nakase K., Miwa H., Masuya M., Nisshii K., Morita N., Takakura N., Otsuji A., Shirakawa S., Ueda T., Nasu K., Kyo T., Dohy H., Kamada N. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD 19 together with stem cell antigen CD34. Blood 1992; 80: 470–477
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein(P-170) expression on acute non-lymphoblastic leukemia cells. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• Te Boekhorst P. A. W., de Leeuw K., Schoester M., Wittebol S., Nooter K., Hagemeijer, Löwenberg B., Sonneveld P. Predominance of functional multidrug resistance (MDR-1) pheno-type in CD34+ acute myeloid leukemia cells. Blood 1993; 82: 3157–3162
   PubMed Web of Science ®Google Scholar
• Guinot M., Sanz G. F., Sempere A., Arilla M. J., Jarque I., Gomis F., Sanz M. A. Prognostic value of CD34 expression in de novo acute myeloblasts leukaemia. Br. J. Haematol. 1991; 79: 533–534
   PubMed Web of Science ®Google Scholar
• Myint H., Lucie N. P. The prognostic significance of the CD34 antigen in acute myeloid leukaemia. Leuk. Lymphoma 1992; 7: 425–429
   PubMed Web of Science ®Google Scholar
• Selleri C., Notaro R., Catalano L., Fontana R., Del Vecchio L., Rotoli B. Prognostic irrelevance of CD34 in acute myeloid leukaemia. Br. J. Haematol. 1992; 82: 479–481
   PubMed Web of Science ®Google Scholar
• Ciolli S., Leoni F., Caporale R., Pascarella A., Salti F., Rossi-Ferrini P. CD34 expression fails to predict the outcome in adult acute myeloid leukemia. Haematologica 1993; 78: 151–155
   PubMed Web of Science ®Google Scholar
• Del Poeta G., Stasi R., Venditti A., Suppo G., Aronica G., Bruno A., Masi M., Tabilio A., Papa G. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994; 8: 388–394
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Shuster I. J., Civin C. I., Caroll A. J., Look A. T., Behm F. G., Land V. J., Pullen D. J., Crist W. M. Prognostic significance of CD34 expression in childhood B-pre-cursor acute lymphocytic leukemia: a pediatric oncology group study. J. Clin. Oncol. 1990; 8: 1389–1398
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Caroll A. J., Shuster J. J., Look A. T., Behm F. G., Pullen D. J., Land V. J., Steuber P., Crist W. M. Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the pediatric oncology group. Recent Advances in Cell Biology of Acute Leukemias, W.-D. Ludwig, E. Thiel. Springer, Berlin, Heidelberg New York 1993; 257–267, (Recent Results in Cancer Research, Vol. 131)
   Google Scholar
• Creutzig U., Ritter J., Zimmermann M., Schellong G. Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the childhood acute myelogenous leukemia study BFM-87. J. Clin. Oncol. 1993; 11: 279–286
   PubMed Web of Science ®Google Scholar
• Büchner T., Hiddemann W., Löffler G., Gassmann W., Maschmeyer G., Heit W., Hossfeld D., Weh H., Ludwig W.-D., Thiel E., Nowrousian M., Aul C., Lengfelder E., Lathan B., Mainzer K., Urbanitz D., Emmerich B., Middelhoff G., Donhuijsen-Ant H. R., Hellriegel K.-P., Heinicke A. Improved cure rate by very early intersification intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML cooperative group. Semin. Hematol 1991; 28: 76–79
   PubMed Web of Science ®Google Scholar
• Buchner T., Hiddemann W., Schaefer U. W., Loffler H., Maschmeyer G., Ludwig W.-D., Aul C., Lathan B., Heinecke A. Combined effect of very early intensification and prolonged post-remission chemotherapy in patients with AML. Leukemia 1992; 6(Suppl. 6)68–70
   Google Scholar
• Creutzig U., Ritter J., Schellong G. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML-BFM-83 as compared with study AML-BFM-78. Blood 1990; 75: 1932–1940
   PubMed Web of Science ®Google Scholar
• Cheson B. D., Casstleth P. A., Head D. R., Schiffer C. A., Bennett J. M., Bloomfield C. D., Brunning R., Gale R. P., Grever M. R., Keating M. J., Sawitsky A., Stass S., Weinstein H., Woods W. G. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol. 1990; 8: 813–819
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gallon D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med. 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gallon D. A. G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Ann. Intern. Med. 1985; 103: 460–462
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br. J. Haematol. 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• Ludwig W.-D., Bartram C. R., Ritter J., Raghavachar A., Hiddemann W., Heil G., Harbott J., Seibt-Jung H., Teichmann J., Riehm H. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988; 71: 1518–1528
   PubMed Web of Science ®Google Scholar
• Harbott J., Ritterbach J., Ludwig W.-D., Bartram C. R., Borkhardt A., Reiter A., Janka-Schaub G., Lampert F. Clinical relevance of chromosomal aberrations in childhood ALL: cytogenetic data of the German therapy studies. Acute leukemias IV. Prognostic factors and treatment strategies, T. Buchner, W. Hiddemann, B. Wormann, G. Schellong, J. Ritter. Springer, Berlin, Heidelberg New York 1994; 317–321, (Haematology and Blood Transfusion, Vol. 36)
   Google Scholar
• Fonatsch C., Schaadt M., Kirchner H., Diehl V. A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int. J. Cancer 1980; 26: 749–756
   PubMed Web of Science ®Google Scholar
• ISCN. An international system for human cytogenetic nomenclature, D. G. Harnden, H. P. Klinger. S. Karger, Basel 1985
   Google Scholar
• ISCN. Guidelines for cancer cytogenetics. Supplement to an international system for human cytogenetic nomenclature, F. Mitelman. S. Karger, Basel 1991
   Google Scholar
• Cox D. R., Oakes D. Analysis of survival data. Chapman and Hall, London 1984
   Google Scholar
• Dercksen M. W., Daams G. M., de Haas M., von dem Bome A. E. G. K., van der Schoot C. E. Characterization of the CD34 cluster. Tissue Antigens 1993; 42: 361, (abstr.)
   Google Scholar
• Hadjadj F., Debre P., Merle-Beral H. H. Immunochemical characterization of the CD34 workshop antibodies. Tissue Antigens 1993; 42: 374, (abstr.)
   Google Scholar
• Lanza F., Rigolin G. R., Moretti S., Latorraca A., Castoldi G. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. Leuk. Lymphoma 1994; 13(Suppl. 1)81–85
   PubMed Web of Science ®Google Scholar
• Koller U., Haas O. A., Ludwig W.-D., Bartram C. R., Harbott J., Panzer-Griimayer R., Hansen-Hagge T., Ritter J., Creutzig U., Knapp W., Gadner H. Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia. Leukemia 1989; 3: 708–714
   PubMed Web of Science ®Google Scholar
• Chabannon C., Wood P., Torok-Storb B. J. Expression of CD7 on normal human myeloid progenitors. J. Immunol. 1992; 149: 2110–2113
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Thiel E., Ludwig W.-D. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia 1993; 7: 489–498
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Sperling C., Ludwig W.-D. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia. Leukemia 1993; 7: 1142–1150
   PubMed Web of Science ®Google Scholar